Yayınlar & Eserler

Yayın Ağı
Makaleler 53
Tümü (53)
SCI-E, SSCI, AHCI (50)
SCI-E, SSCI, AHCI, ESCI (51)
ESCI (1)
Scopus (53)
TRDizin (4)

1. Real-World Outcomes of Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia

Odabasi Giden A., Özatlı D., ERKURT M. A., Karakus A., SİNCAN G., HİNDİLERDEN F., et al.
Hemato , cilt.7, sa.2, 2026 (ESCI, Scopus)

2. Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin’s Lymphoma: A Multi-Center Retrospective Study on Survival and Safety

Bakirtas M., Hindilerden I. Y., Ulu B. U., Ekinci O., Dogu M. H., Aydogdu I., et al.
Indian Journal of Hematology and Blood Transfusion , cilt.42, sa.3, ss.781-791, 2026 (SCI-Expanded, Scopus)

3. Myeloid Sarcoma as a Manifestation of Lineage Switch from B-cell Acute Lymphoblastic Leukemia after Double Allogeneic Stem Cell Transplantation: A Case Report

Şahin R., KORKMAZ S., Erer K., Katırcılar Y.
Acta Haematologica Oncologica Turcica , cilt.59, sa.1, ss.63-65, 2026 (Scopus, TRDizin) Creative Commons License

4. Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study

Seçilmiş S., Kabukçu Hacıoğlu S., HİNDİLERDEN F., Turgut B., Özatlı D., Akgün Çağlıyan G., et al.
Journal of Clinical Medicine , cilt.15, sa.2, 2026 (SCI-Expanded, Scopus)

5. Does body mass index affect stem cell yield in healthy donors?

YILMAZ S., Okumus N., Seyhan M., Sahin R., Korkmaz G., ERKURT M. A., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

6. The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation

BATGİ H., Zorlu T., ERKURT M. A., UZAY A., Hindilerden I. Y., Pepeler M. S., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

7. The comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma

Karakus A., Hatipoglu U., Katircilar Y., ERKURT M. A., YILMAZ S., Cagliyan G. A., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

8. The role of heparin in autologous stem cell mobilization in patients with multiple myeloma

SARICI A., ERKURT M. A., YILMAZ S., Demircioglu S., BERBER İ., BAŞTÜRK A., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

9. Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference on transplant outcomes?

ERKURT M. A., YILMAZ S., NAMDAROĞLU S., Demircioglu S., SARICI A., Cirik S., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

10. Is there a relationship between stem cell yield obtained from healthy donors and healthy donors’ blood type?

Katircilar Y., Sahin A., Aydin M. S., Erer K., ERKURT M. A., NAMDAROĞLU S., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

11. The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes

Aslan Candir B., Okumus N., Hindilerden I. Y., ERKURT M. A., NAMDAROĞLU S., Merter M., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

12. Extranodal Nasal-Type NK/T-Cell Lymphoma Treatment: Analysis from a Multicenter Study

Sahin D., Soyer N., Yeral M., NAMDAROĞLU S., HİNDİLERDEN F., Aydogdu I., et al.
Nigerian Journal of Clinical Practice , cilt.28, sa.5, ss.602-607, 2025 (SCI-Expanded, Scopus)

13. The Effect of Video Streaming with Virtual Reality on Anxiety and Physiological Parameters During Chemotherapy Treatment in Hematologic Malignancy Patients

KORKMAZ S., Korkmaz E.
Acta Haematologica Oncologica Turcica , cilt.58, sa.1, ss.28-35, 2025 (Scopus, TRDizin)

14. Efficacy of Ruxolitinib in the management of chronic GVHD

Giden A. O., ERKURT M. A., Hindilerden I. Y., Hidayet E., BERBER İ., Tiryaki T. O., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

15. What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease?

YİĞENOĞLU T. N., ERKURT M. A., DAĞDAŞ S., Ulu B. U., KUKU İ., Durdu A., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

16. The role of ruxolitinib in the management of acute GVHD

NAMDAROĞLU S., Hidayet E., Aydin M. S., ERKURT M. A., BERBER İ., Cinar O. E., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

17. Is there a relationship between vitamin D levels and graft versus host disease?

YİĞENOĞLU T. N., Ulu B. U., NAMDAROĞLU S., ERKURT M. A., Sahin R., Okumus N., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

18. Are mesenchymal stem cells still effective in acute GvHD management?

Ulu B. U., Hindilerden I. Y., YİĞENOĞLU T. N., Tiryaki T. O., ERKURT M. A., Korkmaz G., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

19. Biographies of the guest editors for the theme papers on graft-versus-host disease (GVHD)

KORKMAZ S., ALTUNTAŞ F.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

20. Effectiveness of ibrutinib in the management of chronic GVHD

ERKURT M. A., SARICI A., Sahin A., BERBER İ., Korkmaz G., KUKU İ., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

21. What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

Ulas T., NAMDAROĞLU S., Hindilerden I. Y., ERKURT M. A., Erer K., YİĞENOĞLU T. N., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

22. Clinical use of CAR T-cells in treating acute lymphoblastic leukemia

KORKMAZ S.
Transfusion and Apheresis Science , cilt.62, sa.2, 2023 (SCI-Expanded, Scopus)

23. International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report

Özatlı D., Giden A. O., ERKURT M. A., KORKMAZ S., BAŞCI S., Ulas T., et al.
Transfusion and Apheresis Science , cilt.62, sa.2, 2023 (SCI-Expanded, Scopus)

24. The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

Akpinar S., Dogu M. H., ÇELİK S., Ekinci O., Hindilerden I. Y., DAL M. S., et al.
Clinical Lymphoma, Myeloma and Leukemia , cilt.22, sa.3, ss.169-173, 2022 (SCI-Expanded, Scopus)

25. The clinicopathological features and survival of Castleman disease: A multicenter Turkish study

Yildiz J., Bagci M., Sayin S., Kaya A., YILMAZ F. H., EKİNCİ O., et al.
European Review for Medical and Pharmacological Sciences , cilt.26, sa.4, ss.1131-1137, 2022 (SCI-Expanded, Scopus)

26. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

BAŞCI S., ATA N., ALTUNTAŞ F., YİĞENOĞLU T. N., DAL M. S., KORKMAZ S., et al.
Internal and Emergency Medicine , cilt.17, sa.1, ss.135-139, 2022 (SCI-Expanded, Scopus)

27. Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

Uncu Ulu B., DAL M. S., Yönal Hindilerden İ., Akay O. M., MEHTAP Ö., BÜYÜKKURT N., et al.
Journal of Chemotherapy , cilt.34, sa.3, ss.190-198, 2022 (SCI-Expanded, Scopus)

28. Retrospective analysis on efficacy of convalescent plasma in acute respiratory distress syndrome due to COVID-19

ERYILMAZ EREN E., Ulu-Kılıç A., KORKMAZ S., Yıldız M., Yüksel R. C., KILINÇ TOKER A., et al.
Sao Paulo Medical Journal , cilt.140, sa.1, 2022 (SCI-Expanded, Scopus)

29. Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients

YİĞENOĞLU T. N., BAŞCI S., Şahin D., Ulaş T., DAL M. S., KORKMAZ S., et al.
Transfusion and Apheresis Science , cilt.60, sa.6, 2021 (SCI-Expanded, Scopus)

30. Efficacy and safety of plasmapheresis in symptomatic hyperviscosity and cast nephropathy: A Multicenter Experience in Turkey

Kalpakci Y., Hacibekiroglu T., Darcin T., AkgunCagliyan G., KIZIL ÇAKAR M., Hacioglu S. K., et al.
Transfusion and Apheresis Science , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

31. Apheresis in patients with sepsis: A multicenter retrospective study

Aydin K., KORKMAZ S., ERKURT M. A., SARICI A., Ekinci O., Baysal N. A., et al.
Transfusion and Apheresis Science , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

32. A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura

BAŞTÜRK A., Sayin S., ERKURT M. A., SARICI A., Ekinci O., Kum A., et al.
Transfusion and Apheresis Science , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

33. Therapeutic plasma exchange for envenomation: Is it reasonable?

BERBER İ., KORKMAZ S., SARICI A., ERKURT M. A., KUKU İ., KAYA E., et al.
Transfusion and Apheresis Science , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

34. Guest Editor's Bio #2: Dr. S. Korkmaz

KORKMAZ S.
Transfusion and Apheresis Science , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

35. Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience

Goren Sahin D., Akay O. M., KEKLİK M., Okan V., Karakus A., DEMİR C., et al.
Annals of Hematology , cilt.100, sa.7, ss.1667-1675, 2021 (SCI-Expanded, Scopus)

36. Pralatrexate experience in peripheral T-cell lymphoma: A multicenter retrospective study from Turkey

DAL M. S., Merdin A., ERKURT M. A., Ekinci Ö., ALBAYRAK M., Hacıoglu S. K., et al.
Journal of B.U.ON. , cilt.26, sa.4, ss.1536-1539, 2021 (SCI-Expanded, Scopus)

37. Efficacy of therapeutic plasma exchange in patients with Crimean-Congo hemorrhagic fever

Beştepe Dursun Z., KORKMAZ S., Türe Z., KAYNAR L., Dursun A., ÇELİK İ.
Journal of Clinical Apheresis , cilt.36, sa.3, ss.390-397, 2021 (SCI-Expanded, Scopus)

38. COVID-19 in hematopoietic cell transplant recipients

ALTUNTAŞ F., ATA N., YİĞENOĞLU T. N., BAŞCI S., DAL M. S., KORKMAZ S., et al.
Bone Marrow Transplantation , cilt.56, sa.4, ss.952-955, 2021 (SCI-Expanded, Scopus) Creative Commons License

39. Convalescent plasma therapy in patients with COVID-19

ALTUNTAŞ F., YİĞENOĞLU T. N., BAŞCI S., DAL M. S., KORKMAZ S., Turgut B., et al.
Transfusion and Apheresis Science , cilt.60, sa.1, 2021 (SCI-Expanded, Scopus)

40. Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): The Turkish hematology research and education group (ThREG)-TMA02 study

Akpınar S., Tekgunduz E., ERKURT M. A., Esen R., Yılmaz M., KARAKUŞ V., et al.
Transfusion and Apheresis Science , 2021 (SCI-Expanded, Scopus)

41. COVID-19 clinical course and blood groups: Turkish population-based study

Dal M. S., ATA N., ALTUNTAŞ F., BAŞCI S., YİĞENOĞLU T. N., KORKMAZ S., et al.
Turkish Journal of Medical Sciences , cilt.51, sa.4, ss.1659-1664, 2021 (SCI-Expanded, Scopus, TRDizin)

42. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

BAŞCI S., ATA N., ALTUNTAŞ F., YİĞENOĞLU T. N., DAL M. S., KORKMAZ S., et al.
Journal of Oncology Pharmacy Practice , cilt.26, sa.7, ss.1676-1682, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption

YİĞENOĞLU T. N., Ulas T., DAL M. S., KORKMAZ S., ERKURT M. A., ALTUNTAŞ F.
Transfusion and Apheresis Science , cilt.59, sa.4, 2020 (SCI-Expanded, Scopus)

44. Splenic marginal zone lymphoma in Turkey: Association with hepatitis b instead of hepatitis c virus as an etiologic and possible prognostic factor-A multicenter cohort study Türkiye’de splenik marjinal zon lenfoma: Hepatit c virüs yerine hepatit b virüsünün etiyolojik ve olası prognostik faktör oluşu-çok merkezli kohort çalışması

Okay M., Aslan T., Özdemir E., ÜNER A., AYHAN E. A., Güngör E., et al.
Turkish Journal of Hematology , cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded, Scopus, TRDizin)

45. The Turkish experience with therapeutic plasma exchange: A national survey

KORKMAZ S., Solmaz Medeni S., Demirkan F., BEŞIŞIK S., Altay Dadin S., Akgun Cagliyan G., et al.
Transfusion and Apheresis Science , cilt.58, sa.3, ss.287-292, 2019 (SCI-Expanded, Scopus)

46. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?

KORKMAZ S.
Transfusion and Apheresis Science , cilt.57, sa.1, ss.4-7, 2018 (SCI-Expanded, Scopus)

47. Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapy

Kaya A. H., Tekgündüz E., İLKKILIÇ K., Dal M. S., Merdin A., Karakus A., et al.
Journal of Chemotherapy , cilt.30, sa.1, ss.44-48, 2018 (SCI-Expanded, Scopus)

48. Current status of art mobilization in Myeloma

Sevindik O. G., KORKMAZ S., ALTUNTAŞ F.
Transfusion and Apheresis Science , cilt.56, sa.6, ss.850-853, 2017 (SCI-Expanded, Scopus)

49. What is the role of biosimilar G-CSF agents in hematopoietic stem cell mobilization at present?

KORKMAZ S., ALTUNTAŞ F.
Transfusion and Apheresis Science , cilt.56, sa.6, ss.795-799, 2017 (SCI-Expanded, Scopus)

50. Hematopoietic progenitor cell mobilization

ALTUNTAŞ F., KORKMAZ S.
Transfusion and Apheresis Science , cilt.56, sa.6, ss.787, 2017 (SCI-Expanded, Scopus)

51. Management of mobilization failure in 2017

NAMDAROĞLU S., KORKMAZ S., ALTUNTAŞ F.
Transfusion and Apheresis Science , cilt.56, sa.6, ss.836-844, 2017 (SCI-Expanded, Scopus)

52. The effect of local application of insulin-like growth factor for prevention of inner-ear damage caused by electrode trauma

Gur H., Alimoglu Y., Duzenli U., KORKMAZ S., İNAN S., Olgun L.
Journal of Laryngology and Otology , cilt.131, sa.3, ss.245-252, 2017 (SCI-Expanded, Scopus)

53. Two cases of acute suppurative thyroiditis secondary to piriform sinus fistula

Dokmetas H. S., Koyuncu A., KORKMAZ S., DÖKMETAŞ İ.
Saudi Medical Journal , cilt.29, sa.1, ss.142-143, 2008 (SCI-Expanded, Scopus)
Metrikler

Yayın

53

Yayın (WoS)

51

Yayın (Scopus)

53

H-İndeks (WoS)

9

Atıf (Scopus)

297

H-İndeks (Scopus)

9

Atıf (TrDizin)

5

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

5

Proje

1

Tez Danışmanlığı

5

Açık Erişim

7
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER